CAS NO: | 14636-12-5 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selectivevasopressin V1 receptoragonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research[1][2][3][4][5]. | ||||||||||||||||
IC50& Target | Vasopressin V1 receptor[1] | ||||||||||||||||
体外研究 (In Vitro) | Terlipressin (25 nM; 24-72 hours; IEC-6 cells) treatment significantly improves cell viability, proliferation and apoptosis in IEC-6 cells[1]. Cell Proliferation Assay[1]
| ||||||||||||||||
体内研究 (In Vivo) | Using a mouse nonlethal hepatic ischemia-reperfusion (IR) model, Terlipressin administration significantly ameliorates IR-induced liver apoptosis, necrosis and inflammation[3]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 1227.37 | ||||||||||||||||
Formula | C52H74N16O15S2 | ||||||||||||||||
CAS 号 | 14636-12-5 | ||||||||||||||||
Sequence | Gly-Gly-Gly-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge: Cys4-Cys9) | ||||||||||||||||
Sequence Shortening | GGGCYFQNCPKG-NH2 (Disulfide bridge: Cys4-Cys9) | ||||||||||||||||
中文名称 | 特利加压素 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(81.48 mM;Need ultrasonic) 配制储备液
In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|